Related Experiment Video
Updated: Jun 8, 2026

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice
Published on: October 25, 2024
Imaging in clinical trials
Abstract:
Drug development continues to face challenges to successfully progress the most promising drug candidates through the stages of clinical trials. Given the increasing cost to develop a drug, methods are required to characterise early drug efficacy and safety. Imaging techniques are increasingly used in oncological clinical trials to provide evidence for decision making. With the application of conventional morphological imaging techniques and standardised response criteria based on tumour size measurements, imaging continues to be used to define key study end points. However, functional imaging techniques are likely to play an important role in the evaluation of novel therapeutics, although how these methods are to be optimally applied has yet to be clearly established. The specific challenges of standardising multi-centre imaging in the context of clinical trials are highlighted, including the processes for image acquisition, data analysis and radiological review.
Insights
Drug development faces challenges, necessitating early efficacy and safety assessments. Advanced imaging techniques are crucial for evaluating novel therapeutics in clinical trials, but standardization remains a key issue.
Area of Science:
- Oncology
- Drug Development
- Medical Imaging
Background:
- Drug development is costly and faces challenges in progressing candidates through clinical trials.
- There is a need for methods to characterize early drug efficacy and safety.
- Imaging techniques are increasingly utilized in oncological clinical trials for decision-making.
Purpose of the Study:
- To highlight the role of imaging in oncological clinical trials.
- To discuss the application of conventional and functional imaging in evaluating novel therapeutics.
- To address the challenges of standardizing multi-center imaging in clinical trials.
Main Methods:
- Review of conventional morphological imaging techniques and standardized response criteria.
- Exploration of the potential role of functional imaging techniques.
- Identification of challenges in multi-center imaging standardization, including acquisition, analysis, and review.
Main Results:
- Conventional imaging, based on tumor size, is used for study endpoints.
- Functional imaging holds promise for novel therapeutic evaluation but requires established application methods.
- Standardization of multi-center imaging presents significant challenges.
Conclusions:
- Imaging is vital in oncological clinical trials for assessing drug efficacy and safety.
- Functional imaging offers potential for evaluating new therapeutics, but optimal application needs definition.
- Addressing standardization issues in multi-center imaging is critical for reliable clinical trial outcomes.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Imaging Studies VII: Vascular Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies III: Computed Tomography

